GALERA THERAPEUTICS INC(GRTX)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- IV Rank (30D)
- 0
- Straddle Price
- $1.77
- P/C Vol Ratio
- 0.00
- Exchange
- OTC Link
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +13.93% | 4 |
| Feb | -5.35% | 4 |
| Mar | +2.56% | 4 |
| Apr | -1.44% | 4 |
| May | +7.16% | 4 |
| Jun | -2.78% | 4 |
| Jul | -13.94% | 3 |
| Aug | -23.11% | 3 |
| Sep | +2.88% | 3 |
| Oct | -45.54% | 3 |
| Nov | +8.47% | 3 |
| Dec | +80.38% | 3 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-14 | unknown | 2398.65% | 4.05% | 0.00x | Within |
- IV Rank (30D)
- 0
- IV Rank (7D)
- 0
- Avg IV
- 0.0%
- Straddle (30D)
- $1.77
- Straddle (7D)
- $1.77
- P/C Volume
- 0.00
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2024-05-01 | Yair Schneid | 10%+ Owner | Buy (P) | +2,780,407 | $0.21 | $590.4K | EDGAR |
| 2024-02-26 | Yair Schneid | 10%+ Owner | Buy (P) | +932,402 | $0.18 | $166.4K | EDGAR |
| 2023-07-05 | Linda West | Director | Grant (A) | +23,382 opt | — | EDGAR | |
| 2023-07-05 | Lawrence M Alleva | Director | Grant (A) | +22,762 opt | — | EDGAR | |
| 2023-06-16 | Linda West | Director | Grant (A) | +48,000 opt | — | EDGAR | |
| 2023-06-16 | MICHAEL POWELL | Director | Grant (A) | +64,000 opt | — | EDGAR | |
| 2023-06-16 | Lawrence M Alleva | Director | Grant (A) | +48,000 opt | — | EDGAR | |
| 2023-06-16 | Emmett Cunningham | Director | Grant (A) | +48,000 opt | — | EDGAR | |
| 2023-06-16 | KEVIN G LOKAY | Director | Grant (A) | +48,000 opt | — | EDGAR | |
| 2023-03-20 | Mark Bachleda | Chief Commercial Officer | Buy (P) | +11,000 | $2.25 | $24.7K | EDGAR |
| 2023-03-14 | Mel Sorensen | President and CEO | Buy (P) | +100,000 | $1.68 | $168.1K | EDGAR |
| 2023-03-14 | Chris Degnan | Chief Financial Officer | Buy (P) | +10,000 | $1.96 | $19.6K | EDGAR |
| 2023-02-28 | Jennifer Evans Stacey | See Remarks | Grant (A) | +135,000 opt | — | EDGAR | |
| 2023-02-28 | Chris Degnan | Chief Financial Officer | Grant (A) | +185,000 opt | — | EDGAR | |
| 2023-02-28 | Robert A Beardsley | Chief Operating Officer | Grant (A) | +135,000 opt | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Yair Schneid | 10%+ Owner | 10,393,221 | $1.51M | $756.8K | 2 | 2024-05-01 |
| 2 | Novartis Bioventures Ltd | 10%+ Owner | 7,012,340 | $1.02M | -$11.18M | 4 | 2020-06-22 |
| 3 | Anthony A. Jr. Florence | 10%+ Owner | 3,941,381 | $571.5K | $50.00M | 1 | 2019-11-12 |
| 4 | NOVARTIS AG | 10%+ Owner | 3,489,559 | $506.0K | -$729.4K | 2 | 2020-06-12 |
| 5 | Sofinnova Management IX, L.L.C. | 10%+ Owner | 3,083,712 | $447.1K | $45.00M | 1 | 2019-11-12 |
| 6 | Novo Holdings A/S | 10%+ Owner | 2,459,021 | $356.6K | -$4.24M | 3 | 2021-02-19 |
| 7 | Clarus IV-C, L.P. | 10%+ Owner | 555,193 | $80.5K | $15.00M | 1 | 2019-11-14 |
| 8 | Blackstone Clarus GP L.L.C. | 10%+ Owner | 461,769 | $67.0K | $21.00M | 1 | 2019-11-14 |
| 9 | Mel Sorensen | President and CEO | 332,044 | $48.1K | $168.1K | 6 | 2023-03-14 |
| 10 | Robert A Beardsley | Chief Operating Officer | 108,191 | $15.7K | $0 | 8 | 2023-02-28 |
| 11 | Linda West | Director | 60,000 | $8.7K | $405.4K | 10 | 2023-07-05 |
| 12 | Mark Bachleda | Chief Commercial Officer | 11,000 | $1.6K | $24.7K | 4 | 2023-03-20 |
| 13 | Lawrence M Alleva | Director | 10,370 | $1.5K | $97.7K | 10 | 2023-07-05 |
| 14 | Chris Degnan | Chief Financial Officer | 10,000 | $1.4K | $19.6K | 6 | 2023-03-14 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.